Eishi Noguchi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Eishi Noguchi has a total of 183 co-authors. Here are the top co-authors by number of shared publications:
Chiaki Noguchi
Department of Biochemistry & Molecular Biology, Drexel University College of Medicine, Philadelphia, PA, USA
26 shared publicationsTakeharu Nishimoto
Department of Molecular Biology, Graduate School of Medical Science, Kyushu University, Fukuoka 812-8582
7 shared publicationsPaul Russell
Departments of Molecular Biology and Cell Biology, The Scripps Research Institute, La Jolla, California 92037, USA
6 shared publications- Toru M. Nakamura
College of Medicine, University of Illinois Chicago
6 shared publications Adam R. Leman
Duke University
5 shared publicationsAlison B. Ansbach
Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, Pennsylvania, United States of America
4 shared publications
Latest Publications
- 14 November 2026
- Published by Drexel University Libraries
DDX11 as a potential therapeutic target in esophageal squamous cell carcinoma
Esophageal squamous cell carcinoma (ESCC) is characterized by uncontrolled cell growth, elevated replication stress, genomic instability, and accumulation of DNA damage, yet effective therapeutic options remain limited. To sustain rapid growth under these conditions, cancer cells rely on replication stress response and DNA repair pathways that preserve genomic integrity. DDX11 is a DNA helicase that is upregulated in multiple cancer types, including ESCC and related head and neck squamous cell carcinoma. DDX11 interacts with Timeless, a component of the fork-protection complex, and resolves replication barriers such as G-quadruplexes (G4s), suggesting its role in maintaining fork integrity and genomic stability. Despite these established functions, the role of DDX11 in ESCC remains unknown. Here, we investigated the consequences of DDX11 depletion and evaluated its potential as a therapeutic target. We found that DDX11 loss increased replication stress and DNA damage, as demonstrated by elevated phosphorylation of the replication checkpoint kinases Chk1 and RPA32, and increased expression of the compensatory helicase FANCJ. DDX11 depletion also led to activation of the cGAS-STING innate immune signaling pathway, with alteration in the expression of downstream inflammatory cytokines. Furthermore, loss of DDX11 also sensitized cancer cells to G4 stabilizers and PARP inhibitors. Together, these findings demonstrate that DDX11 is required for maintaining fork integrity and renders ESCC cells more susceptible to targeted therapies, supporting DDX11 as a promising therapeutic target.
- 14 November 2026
- Published by Drexel University Libraries
DDX11 as a potential therapeutic target in esophageal squamous cell carcinoma
Esophageal squamous cell carcinoma (ESCC) is characterized by uncontrolled cell growth, elevated replication stress, genomic instability, and accumulation of DNA damage, yet effective therapeutic options remain limited. To sustain rapid growth under these conditions, cancer cells rely on replication stress response and DNA repair pathways that preserve genomic integrity. DDX11 is a DNA helicase that is upregulated in multiple cancer types, including ESCC and related head and neck squamous cell carcinoma. DDX11 interacts with Timeless, a component of the fork-protection complex, and resolves replication barriers such as G-quadruplexes (G4s), suggesting its role in maintaining fork integrity and genomic stability. Despite these established functions, the role of DDX11 in ESCC remains unknown. Here, we investigated the consequences of DDX11 depletion and evaluated its potential as a therapeutic target. We found that DDX11 loss increased replication stress and DNA damage, as demonstrated by elevated phosphorylation of the replication checkpoint kinases Chk1 and RPA32, and increased expression of the compensatory helicase FANCJ. DDX11 depletion also led to activation of the cGAS-STING innate immune signaling pathway, with alteration in the expression of downstream inflammatory cytokines. Furthermore, loss of DDX11 also sensitized cancer cells to G4 stabilizers and PARP inhibitors. Together, these findings demonstrate that DDX11 is required for maintaining fork integrity and renders ESCC cells more susceptible to targeted therapies, supporting DDX11 as a promising therapeutic target.
- Open Access
- 12 August 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (8) , 1177
Evolutionarily Conserved but Mechanistically Distinct Mitochondrial Responses to Loss of Timeless/Swi1
Timeless and its fission yeast ortholog Swi1 are evolutionarily conserved components of the replication fork protection complex that ensures faithful DNA replication and genome stability. While their nuclear roles are well-characterized, their roles in mitochondrial genome maintenance remain unknown. Here, we demonstrate a previously unrecognized connection between Timeless/Swi1 and mitochondrial homeostasis. In fission yeast, swi1 deletion increased association of the DNA repair protein Rad52 with mitochondrial DNA sequences across the mitochondrial genome, suggesting altered mitochondrial genome maintenance. Unexpectedly, swi1∆ cells showed an increased mtDNA copy number and improved growth under respiratory conditions, suggesting activation of compensatory mechanisms that promote mitochondrial genome maintenance. The loss of Swi1 also partially rescued the growth defect under respiratory conditions and mtDNA loss associated with depletion of mitochondrial DNA polymerase γ, linking Swi1 to pathways regulating mitochondrial replication under stress. Consistent with these phenotypes, transcriptomic and pathway enrichment analyses revealed transcriptional changes indicative of reduced glycolysis and enhanced oxidative phosphorylation, suggesting a shift toward respiratory metabolism. In human cells, Timeless depletion elicited distinct mitochondrial responses depending on the cell type. While Timeless-depleted TE-11 and Saos-2 cells elicited mitochondrial phenotypes comparable to those observed in fission yeast, Timeless depletion in U-2 OS cells led to reduced mtDNA copy number, elevated mitochondrial reactive oxygen species, and decreased mitochondrial membrane potential and mass, consistent with mitochondrial dysfunction. Despite these phenotypic differences, both fission yeast and human cells exhibited elevated levels of orthologs of the mitochondrial transcription factor A (TFAM) and the oxidative stress regulator NRF2, suggesting the conserved activation of compensatory mitochondrial and antioxidant pathways. Together, these findings identify an evolutionarily conserved connection between Timeless/Swi1 and mitochondrial homeostasis and reveal distinct adaptive responses to mitochondrial stress.
- 12 August 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (8) , 1177
Open AccessEvolutionarily Conserved but Mechanistically Distinct Mitochondrial Responses to Loss of Timeless/Swi1
Timeless and its fission yeast ortholog Swi1 are evolutionarily conserved components of the replication fork protection complex that ensures faithful DNA replication and genome stability. While their nuclear roles are well-characterized, their roles in mitochondrial genome maintenance remain unknown. Here, we demonstrate a previously unrecognized connection between Timeless/Swi1 and mitochondrial homeostasis. In fission yeast, swi1 deletion increased association of the DNA repair protein Rad52 with mitochondrial DNA sequences across the mitochondrial genome, suggesting altered mitochondrial genome maintenance. Unexpectedly, swi1∆ cells showed an increased mtDNA copy number and improved growth under respiratory conditions, suggesting activation of compensatory mechanisms that promote mitochondrial genome maintenance. The loss of Swi1 also partially rescued the growth defect under respiratory conditions and mtDNA loss associated with depletion of mitochondrial DNA polymerase γ, linking Swi1 to pathways regulating mitochondrial replication under stress. Consistent with these phenotypes, transcriptomic and pathway enrichment analyses revealed transcriptional changes indicative of reduced glycolysis and enhanced oxidative phosphorylation, suggesting a shift toward respiratory metabolism. In human cells, Timeless depletion elicited distinct mitochondrial responses depending on the cell type. While Timeless-depleted TE-11 and Saos-2 cells elicited mitochondrial phenotypes comparable to those observed in fission yeast, Timeless depletion in U-2 OS cells led to reduced mtDNA copy number, elevated mitochondrial reactive oxygen species, and decreased mitochondrial membrane potential and mass, consistent with mitochondrial dysfunction. Despite these phenotypic differences, both fission yeast and human cells exhibited elevated levels of orthologs of the mitochondrial transcription factor A (TFAM) and the oxidative stress regulator NRF2, suggesting the conserved activation of compensatory mitochondrial and antioxidant pathways. Together, these findings identify an evolutionarily conserved connection between Timeless/Swi1 and mitochondrial homeostasis and reveal distinct adaptive responses to mitochondrial stress.
- Open Access
Senescent and reactive astrocytes display distinct expression profiles and divergent functional capacities.
Astrocytes assume multiple phenotypes in the brain in response to stress, injury, inflammation, and aging. Given the complexity of this critical cell type in the CNS, it is important to gain a greater understanding of the differences between these phenotypes and to potentially identify therapeutic approaches to modifying astrocyte function in the context of disease and aging. We compared senescent and reactive astrocytes using a strictly defined paradigm to induce these phenotypes in human astrocytes. Gene expression profiling reveals overlapping but distinct expression profiles. Reactive astrocytes predominantly express genes involved in inflammatory responses while senescent astrocytes express genes and a secretome that suggests a role in synaptic pruning. Unexpectedly, functional analysis in a simplified neurite outgrowth assay suggests that senescent astrocytes retain the ability to support neurite outgrowth while reactive astrocytes lose this capacity. The data suggests that senescent and reactive astrocytes play distinct functional roles in the physiology of the aging brain. However, the overlapping inflammatory nature of senescent and reactive astrocytes makes it difficult to discriminate between them using existing toolsets designed to identify senescent cells.
Open AccessSenescent and reactive astrocytes display distinct expression profiles and divergent functional capacities.
Astrocytes assume multiple phenotypes in the brain in response to stress, injury, inflammation, and aging. Given the complexity of this critical cell type in the CNS, it is important to gain a greater understanding of the differences between these phenotypes and to potentially identify therapeutic approaches to modifying astrocyte function in the context of disease and aging. We compared senescent and reactive astrocytes using a strictly defined paradigm to induce these phenotypes in human astrocytes. Gene expression profiling reveals overlapping but distinct expression profiles. Reactive astrocytes predominantly express genes involved in inflammatory responses while senescent astrocytes express genes and a secretome that suggests a role in synaptic pruning. Unexpectedly, functional analysis in a simplified neurite outgrowth assay suggests that senescent astrocytes retain the ability to support neurite outgrowth while reactive astrocytes lose this capacity. The data suggests that senescent and reactive astrocytes play distinct functional roles in the physiology of the aging brain. However, the overlapping inflammatory nature of senescent and reactive astrocytes makes it difficult to discriminate between them using existing toolsets designed to identify senescent cells.
- 17 November 2025
- Published by Elsevier in Experimental Cell Research
- Vol. 455 (1) , 114828
Timeless prevents senescence-associated phenotypes and enhances DNA repair to promote esophageal cancer cell growth
- 17 November 2025
- Published by Elsevier in Experimental Cell Research
- Vol. 455 (1) , 114828
Timeless prevents senescence-associated phenotypes and enhances DNA repair to promote esophageal cancer cell growth
- 3 October 2024
- Published by Drexel University Libraries
The role of DDX11 in telomere maintenance and its implications in cancer cells
Telomeres are enriched with G-quadruplexes (G4s), four-stranded DNA structures stabilized by the formation of bonds between guanine nucleotides. If not properly regulated, G4s can lead to detrimental effects on telomere maintenance, which is essential for cancer proliferation. Therefore, G4 ligands that block telomere maintenance are considered promising cancer therapeutics. Recent studies reported a role of DDX11 in G4 resolution. DDX11 is a DNA helicase that plays a crucial role in maintaining genomic stability by participating in DNA replication and repair. DDX11 is also overexpressed in some cancer cells, and in recent years, a possible oncogenic role of DDX11 in the onset and progression of many cancers has been emerging. This thesis aims to critically evaluate the current understanding of DDX11 and its potential relationship with telomere maintenance. Using molecular cell biology and genetic approaches, we are exploring how DDX11 deficiency affects telomeric replication and genomic integrity. We anticipate that our research will offer new insights into the pathogenesis of cancer and contribute to the development of novel therapeutic strategies for cancer treatment.
- 3 October 2024
- Published by Drexel University Libraries
The role of DDX11 in telomere maintenance and its implications in cancer cells
Telomeres are enriched with G-quadruplexes (G4s), four-stranded DNA structures stabilized by the formation of bonds between guanine nucleotides. If not properly regulated, G4s can lead to detrimental effects on telomere maintenance, which is essential for cancer proliferation. Therefore, G4 ligands that block telomere maintenance are considered promising cancer therapeutics. Recent studies reported a role of DDX11 in G4 resolution. DDX11 is a DNA helicase that plays a crucial role in maintaining genomic stability by participating in DNA replication and repair. DDX11 is also overexpressed in some cancer cells, and in recent years, a possible oncogenic role of DDX11 in the onset and progression of many cancers has been emerging. This thesis aims to critically evaluate the current understanding of DDX11 and its potential relationship with telomere maintenance. Using molecular cell biology and genetic approaches, we are exploring how DDX11 deficiency affects telomeric replication and genomic integrity. We anticipate that our research will offer new insights into the pathogenesis of cancer and contribute to the development of novel therapeutic strategies for cancer treatment.
- 17 September 2023
- Published by Taylor & Francis in Cell Cycle
- Vol. 22 (18) , 2088-2096
The p53 DNA damage response and Fanconi anemia DNA repair pathway protect against acetaldehyde-induced replication stress in esophageal keratinocytes
Alcohol contributes to cellular accumulation of acetaldehyde, a primary metabolite of alcohol and a major human carcinogen. Acetaldehyde can form DNA adducts and induce interstrand crosslinks (ICLs) that are repaired by the Fanconi anemia DNA repair pathway (FA pathway). Individuals with deficiency in acetaldehyde detoxification or in the FA pathway have an increased risk of squamous-cell carcinomas (SCCs) including those of the esophagus. In a recent report, we described the molecular basis of acetaldehyde-induced DNA damage in esophageal keratinocytes [1]. We demonstrated that, at physiologically relevant concentrations, acetaldehyde induces DNA damage at the DNA replication fork. This resulted in replication stress, leading to activation of the ATR-Chk1-dependent cell cycle checkpoints. We also reported that the p53 DNA damage response is elevated in response to acetaldehyde and that the FA pathway limits acetaldehyde-induced genomic instability. Here, we highlight these findings and present additional results to discuss the role of the FA pathway and p53 DNA damage response in the protection against genomic instability and esophageal carcinogenesis.
- 17 September 2023
- Published by Taylor & Francis in Cell Cycle
- Vol. 22 (18) , 2088-2096
The p53 DNA damage response and Fanconi anemia DNA repair pathway protect against acetaldehyde-induced replication stress in esophageal keratinocytes
Alcohol contributes to cellular accumulation of acetaldehyde, a primary metabolite of alcohol and a major human carcinogen. Acetaldehyde can form DNA adducts and induce interstrand crosslinks (ICLs) that are repaired by the Fanconi anemia DNA repair pathway (FA pathway). Individuals with deficiency in acetaldehyde detoxification or in the FA pathway have an increased risk of squamous-cell carcinomas (SCCs) including those of the esophagus. In a recent report, we described the molecular basis of acetaldehyde-induced DNA damage in esophageal keratinocytes [1]. We demonstrated that, at physiologically relevant concentrations, acetaldehyde induces DNA damage at the DNA replication fork. This resulted in replication stress, leading to activation of the ATR-Chk1-dependent cell cycle checkpoints. We also reported that the p53 DNA damage response is elevated in response to acetaldehyde and that the FA pathway limits acetaldehyde-induced genomic instability. Here, we highlight these findings and present additional results to discuss the role of the FA pathway and p53 DNA damage response in the protection against genomic instability and esophageal carcinogenesis.
- Open Access
lncRNA H19/Let7b/EZH2 axis regulates somatic cell senescence
Long non-coding RNAs (lncRNAs) regulate diverse cellular processes and are associated with many age-associated diseases. However, the function of lncRNAs in cellular senescence remains largely unknown. Here we characterize the role of lncRNA H19 in senescence. We show that H19 levels decline as cells undergo senescence, and depletion of H19 results in premature senescence. We find that repression of H19 is triggered by the loss of CTCF and prolonged activation of p53 as part of the senescence pathway. Mechanistically, the loss of H19 drives senescence via increased let7b mediated targeting of EZH2. We further demonstrate that H19 is required for senescence inhibition by the mTOR inhibitor rapamycin, where it maintains lncRNA H19 levels throughout the cellular lifespan and thus prevents the reduction of EZH2 that would otherwise lead to cellular senescence. Therefore, lncRNA H19 is crucial in maintaining the balance between sustained cell growth and the onset of senescence.
Open AccesslncRNA H19/Let7b/EZH2 axis regulates somatic cell senescence
Long non-coding RNAs (lncRNAs) regulate diverse cellular processes and are associated with many age-associated diseases. However, the function of lncRNAs in cellular senescence remains largely unknown. Here we characterize the role of lncRNA H19 in senescence. We show that H19 levels decline as cells undergo senescence, and depletion of H19 results in premature senescence. We find that repression of H19 is triggered by the loss of CTCF and prolonged activation of p53 as part of the senescence pathway. Mechanistically, the loss of H19 drives senescence via increased let7b mediated targeting of EZH2. We further demonstrate that H19 is required for senescence inhibition by the mTOR inhibitor rapamycin, where it maintains lncRNA H19 levels throughout the cellular lifespan and thus prevents the reduction of EZH2 that would otherwise lead to cellular senescence. Therefore, lncRNA H19 is crucial in maintaining the balance between sustained cell growth and the onset of senescence.
- 21 May 2022
- Published by Springer Nature in Human Genetics
- Vol. 141 (12) , 1811-1836
Fanconi anemia: current insights regarding epidemiology, cancer, and DNA repair
Fanconi anemia is a genetic disorder that is characterized by bone marrow failure, as well as a predisposition to malignancies including leukemia and squamous cell carcinoma (SCC). At least 22 genes are associated with Fanconi anemia, constituting the Fanconi anemia DNA repair pathway. This pathway coordinates multiple processes and proteins to facilitate the repair of DNA adducts including interstrand crosslinks (ICLs) that are generated by environmental carcinogens, chemotherapeutic crosslinkers, and metabolic products of alcohol. ICLs can interfere with DNA transactions, including replication and transcription. If not properly removed and repaired, ICLs cause DNA breaks and lead to genomic instability, a hallmark of cancer. In this review, we will discuss the genetic and phenotypic characteristics of Fanconi anemia, the epidemiology of the disease, and associated cancer risk. The sources of ICLs and the role of ICL-inducing chemotherapeutic agents will also be discussed. Finally, we will review the detailed mechanisms of ICL repair via the Fanconi anemia DNA repair pathway, highlighting critical regulatory processes. Together, the information in this review will underscore important contributions to Fanconi anemia research in the past two decades.
- 21 May 2022
- Published by Springer Nature in Human Genetics
- Vol. 141 (12) , 1811-1836
Fanconi anemia: current insights regarding epidemiology, cancer, and DNA repair
Fanconi anemia is a genetic disorder that is characterized by bone marrow failure, as well as a predisposition to malignancies including leukemia and squamous cell carcinoma (SCC). At least 22 genes are associated with Fanconi anemia, constituting the Fanconi anemia DNA repair pathway. This pathway coordinates multiple processes and proteins to facilitate the repair of DNA adducts including interstrand crosslinks (ICLs) that are generated by environmental carcinogens, chemotherapeutic crosslinkers, and metabolic products of alcohol. ICLs can interfere with DNA transactions, including replication and transcription. If not properly removed and repaired, ICLs cause DNA breaks and lead to genomic instability, a hallmark of cancer. In this review, we will discuss the genetic and phenotypic characteristics of Fanconi anemia, the epidemiology of the disease, and associated cancer risk. The sources of ICLs and the role of ICL-inducing chemotherapeutic agents will also be discussed. Finally, we will review the detailed mechanisms of ICL repair via the Fanconi anemia DNA repair pathway, highlighting critical regulatory processes. Together, the information in this review will underscore important contributions to Fanconi anemia research in the past two decades.
- Open Access
- 7 October 2021
- Published by MDPI AG in Biomolecules
- Vol. 11 (10) , 1479
Alcohol Metabolism Enriches Squamous Cell Carcinoma Cancer Stem Cells That Survive Oxidative Stress via Autophagy
Background: Alcohol (ethanol) consumption is a major risk factor for head and neck and esophageal squamous cell carcinomas (SCCs). However, how ethanol (EtOH) affects SCC homeostasis is incompletely understood. Methods: We utilized three-dimensional (3D) organoids and xenograft tumor transplantation models to investigate how EtOH exposure influences intratumoral SCC cell populations including putative cancer stem cells defined by high CD44 expression (CD44H cells). Results: Using 3D organoids generated from SCC cell lines, patient-derived xenograft tumors, and patient biopsies, we found that EtOH is metabolized via alcohol dehydrogenases to induce oxidative stress associated with mitochondrial superoxide generation and mitochondrial depolarization, resulting in apoptosis of the majority of SCC cells within organoids. However, CD44H cells underwent autophagy to negate EtOH-induced mitochondrial dysfunction and apoptosis and were subsequently enriched in organoids and xenograft tumors when exposed to EtOH. Importantly, inhibition of autophagy increased EtOH-mediated apoptosis and reduced CD44H cell enrichment, xenograft tumor growth, and organoid formation rate. Conclusions: This study provides mechanistic insights into how EtOH may influence SCC cells and establishes autophagy as a potential therapeutic target for the treatment of EtOH-associated SCC.
- 7 October 2021
- Published by MDPI AG in Biomolecules
- Vol. 11 (10) , 1479
Open AccessAlcohol Metabolism Enriches Squamous Cell Carcinoma Cancer Stem Cells That Survive Oxidative Stress via Autophagy
Background: Alcohol (ethanol) consumption is a major risk factor for head and neck and esophageal squamous cell carcinomas (SCCs). However, how ethanol (EtOH) affects SCC homeostasis is incompletely understood. Methods: We utilized three-dimensional (3D) organoids and xenograft tumor transplantation models to investigate how EtOH exposure influences intratumoral SCC cell populations including putative cancer stem cells defined by high CD44 expression (CD44H cells). Results: Using 3D organoids generated from SCC cell lines, patient-derived xenograft tumors, and patient biopsies, we found that EtOH is metabolized via alcohol dehydrogenases to induce oxidative stress associated with mitochondrial superoxide generation and mitochondrial depolarization, resulting in apoptosis of the majority of SCC cells within organoids. However, CD44H cells underwent autophagy to negate EtOH-induced mitochondrial dysfunction and apoptosis and were subsequently enriched in organoids and xenograft tumors when exposed to EtOH. Importantly, inhibition of autophagy increased EtOH-mediated apoptosis and reduced CD44H cell enrichment, xenograft tumor growth, and organoid formation rate. Conclusions: This study provides mechanistic insights into how EtOH may influence SCC cells and establishes autophagy as a potential therapeutic target for the treatment of EtOH-associated SCC.